Sunday 9 August 2020 ,
Sunday 9 August 2020 ,
Latest News
  • Coronavirus: Bangladesh detects 2,611 new cases, 32 more die
  • 8 more deaths take flood death toll to 169
  • First Covid-19 vaccine to get registered on 12th Aug in Russia
  • Bangladesh’s Covid-19 cases surpass 2.5 lakh
  • 27 more die, 2,851 new cases reported in 24 hours
  • Mountaineer Reshma killed in road crash
  • TikTok threatens legal action against US ban
  • Coronavirus cases worldwide pass 19 million
  • Bangladesh among global hotspots of series of floods: Study
  • WHO says ‘vaccine nationalism’ cannot beat virus
15 July, 2020 11:05:10 PM / LAST MODIFIED: 16 July, 2020 03:39:44 PM
Print

Moderna to start final clinical trial for Covid-19 vaccine in July

Independent Online/UNB
Moderna to start final clinical trial for Covid-19 vaccine in July

US biotech company Moderna has planned to begin its final phase of testing its COVID-19 vaccine on July 27, according to details posted Tuesday on government database clinicaltrials.gov.

Researchers planned to enroll 30,000 adult participants, including people whose locations or circumstances put them at high-risk of infection. Participants will either receive the vaccine or a placebo, reports Xinhua.

The Cambridge, Massachusetts-based biotech company, is the first to announce a start date for phase 3 study in the United States.

The study aims to evaluate the efficacy, safety, and immunogenicity of the mRNA-1273 SARS-CoV-2 vaccine in adults aged 18 years and older, according to information on the website, which is maintained by the US National Library of Medicine of the National Institutes of Health.

Researchers will evaluate whether the participants develop COVID-19 14 days after they get their second dose. The participants will be followed for two years after receiving their second dose.

The study will be conducted at 87 locations across the US.

According to Anthony Fauci, director of the US National Institute of Allergy and Infectious Diseases, the phase 3 trials will begin with one by Moderna in July, then an Oxford/AstraZeneca vaccine in August and one by Johnson & Johnson in September.

MH

 

 

Comments

Video

Copyright © All right reserved.

Editor : M. Shamsur Rahman

Published by the Editor on behalf of Independent Publications Limited at Media Printers, 446/H, Tejgaon I/A, Dhaka-1215.
Editorial, News & Commercial Offices : Beximco Media Complex, 149-150 Tejgaon I/A, Dhaka-1208, Bangladesh. GPO Box No. 934, Dhaka-1000.

Editor : M. Shamsur Rahman
Published by the Editor on behalf of Independent Publications Limited at Media Printers, 446/H, Tejgaon I/A, Dhaka-1215.
Editorial, News & Commercial Offices : Beximco Media Complex, 149-150 Tejgaon I/A, Dhaka-1208, Bangladesh. GPO Box No. 934, Dhaka-1000.

Disclaimer & Privacy Policy
....................................................
About Us
....................................................
Contact Us
....................................................
Advertisement
....................................................
Subscription

Powered by : Frog Hosting